SlideShare a Scribd company logo
HIV incidence in Republic of Karelia.
Chemoprevention of mother-to-child
transmission of HIV
Министерство здравоохранения
Республики Карелия
Kaliningrad
Elena Kuzmicheva
HIV incidence and prevalence in Republic of Karelia
In 2016, 175 HIV cases were diagnosed, of whom 161 among residents
of Karelia.
HIV incidence amounted to 25,5 per 100,000 population, which is by
11,5% lower than the 2015 incidence rate
From January to May 2017, 78 HIV cases were diagnosed, of whom 72
were residents of Karelia.
The incidence was 11,4 per 100,000 population, which is by 22,6% higher
than in the similar period of 2016 (9,3 per 100,000)
As of 1.6.2017, totally 1,989 HIV cases were diagnosed in Karelia, of
whom 1,662 were Karelia’s residents. The prevalence is 263,9 per
100,000 population.
Министерство здравоохранения
Республики Карелия
HIV incidence and prevalence
Министерство здравоохранения
Республики Карелия
incidence
HIV incidence and prevalence by municipality
• In some municipalities the HIV rates are higher than the Russian average rates (594,3 per
100,000 population as of 1.1.2017)
234,6
445,9
662,5
105,7
212,4
63,5
205,5
453,4
1094,9
139,9 123,4
313,2
263,0
215,3
103,8
158,7 168,8
204,9
263,9
594,3
0,0
200,0
400,0
600,0
800,0
1000,0
Районы республики
Республика Карелия
Российская Федерация
Municipalities
Karelia
Russia
Министерство здравоохранения
Республики Карелия
Distribution of PLWHs by gender
• Women make up 37,3% in the total
HIV+ population 62,7%
37,3%
53,7
57,8
67,1
51,7
62,9
69,9
61,8
75,4
60,0
66,5
55,0 55,2 58,5 59,4 61,5
46,3
42,2
32,9
48,3
37,1
30,1
38,2
24,6
40,0
33,5
45,0 44,8 41,5 40,6 38,5
0 %
25 %
50 %
75 %
100 %
2003 г. 2004 г. 2005 г. 2006 г. 2007 г. 2008 г. 2009 г. 2010 г. 2011 г. 2012 г. 2013 г. 2014 г. 2015 г. 2016 г. 2017 г.
женщины
мужчины
Females
Males
Министерство здравоохранения
Республики Карелия
Age structure of the HIV+ population
• Among all PLWHs, the share of the young population aged 20-29 years is
45,5%, and aged 30-34 years – 34,0%
0-14 лет;
0,6% 15-19 лет;
4,9%
20-29 лет;
45,5%
30-39 лет;
34,0%
40-49 лет;
10,6%
50 и старше;
4,3%
Министерство здравоохранения
Республики Карелия
Changes in the age structure of the HIV+ population
• More HIV+ people in senior
age groups
• In 2011, aged 20-29 made
44,2%,
30-39 years – 39,5%,
40-49 years – 10,9%,
Over 50 years – 1,8%.
• In 2016,
20-29 years - 19,4%,
30-39 years – 45,7%,
40-49 years – 21,7%,
Over 50 years – 9,7%.
0,6 1,2 0,5 0,5 0,62,7 3,0 3,0
1,9 3,3 2,0 2,9
37,7
44,2 44,3
35,0
35,0 36,5
19,4
23,1
41,2
39,5 37,1
41,9 40,4 40,5
45,7
35,9
11,4
10,9
9,6
16,2 14,8 16,5
21,7
28,2
7,0
1,8 4,8 5,0 6,0 4,0
9,7 12,8
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
2010г. 2011г. 2012г. 2013г. 2014г. 2015г. 2016г. 2017г.
50 и старше 40-49 лет 30-39 лет 20-29 лет 15-19 лет 0-14 лет
Министерство здравоохранения
Республики Карелия
Age structure of HIV+ women
• Women prevail over men in age groups 15-19 years, 20-29 years and over 50 years.
The leading age groups, alike with men, are 20-29 years and 30-39 years
0-14 yo;
0,3%
15-19 yo;
6,9%
20-29 yo;
46,1%
30-39 yo;
29,6%
40-49 yo;
10,8%
50 and older;
6,3%
Министерство здравоохранения
Республики Карелия
Key transmission routes
43 %
55 %
1 %0 %
1 %
Заражение при
употреблении в/в
наркотиков
Заражение при
гетеросексуальных
контактах
Заражение при
гомосексуальных контактах
Заражение при
парентеральных
вмешательствах в ЛПУ
Заражение от матери во
время беременности и
родов
Министерство здравоохранения
Республики Карелия
IDU
Heterosexual contacts
Homosexual contacts
Blood products in healthcare sector
Mother-to-child
Key transmission routes
32,7
51,3 54,3
40,6 41,4
45,1
40,8
34,1
28,6
33,3 30,3 27,8
65,5
47,4 44,7
52,2
58,6 54,0
56,9
65,1
69,4
64,2
68,0 70,4
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
2006 г. 2007 г. 2008 г. 2009 г. 2010 г. 2011 г. 2012 г. 2013 г. 2014 г. 2015 г. 2016 г. 2017 г.
Заражение при употреблении в/в наркотиков Заражение при гомосексуальных контактах
Заражение при гетеросексуальных контактах Заражение от матери во время беременности и родов
Заражение при парентеральных вмешательствах в ЛПУ
IDU
Heterosexual contacts
Blood products
Homosexual contacts
MTCT
Министерство здравоохранения
Республики Карелия
Follow-up care for pregnant women and children born to HIV+
mothers
As of 01.06.2017:
Abortion – 145
Deliveries – 284, of which in 2016 – 32, in 2017 - 12.
HIV diagnosed with 11 children, of whom born in Karelia – 10 (of whom in 2014
– 1, in 2015 – 1, in 2016 – 1).
Died of HIV – 2 children, moved from Karelia – 2.
Under follow-up – 9 children (7 born in Karelia and 2 arrived from other
regions). All receive ARVT
Министерство здравоохранения
Республики Карелия
Child deliveries among HIV+ women in Republic of Karelia
1
8
5
10
8
11
7
16
18
16
26
20
28
35
31
32
12
0
10
20
30
1999 г.2000 г.2001 г.2002 г.2003 г.2004 г.2005 г.2006 г.2007 г.2008 г.2009 г.2010 г.2011 г.2012 г. 2013г. 2014г. 2015г. 2016г. 2017г.
Absolutenumber
Министерство здравоохранения
Республики Карелия
Coverage with chemotherapy
80,8
95,0
89,3
97,1 96,9
93,7
83,3
80,8
85,0
82,2
88,6
93,7 93,7
83,3
96,1
100,0
96,4
100,0 100,0 100,0 100
80,8
85,0
82,2
88,6
93,7
90,6
83,3
0,0
20,0
40,0
60,0
80,0
100,0
2011 2012 2013 2014 2015 2016 2017
% беременных,
получивших
ВААРТ или ХП
во время
беременности
% беременных,
получивших ХП
во время родов
%
новорожденных,
получивших ХП
% пар мать-дитя,
получвших
трехэтапную ХП
Министерство здравоохранения
Республики Карелия
% of pregnant
women who
received ARVT or
chemotherapy
during pregnancy
% of pregnant
women who
received
chemotherapy
during pregnancy
% of newborns
who received
chemotherapy
% of mother-child
couples who
received 3-stage
chemotherapy
Summary of 2016
In 2016, out of 32 pregnant women, 30 were in follow-up in women’s clinics
and AIDS Centre (93,7%), average for Russia – 92,0%.
 Chemotherapy:
• - in pregnancy– 30 (93,7%), average for Russia – 89%,
 29 women had undetectable viral load (91,6%, average for Russia – 79%)
• - during labours – 30 (93,7%), average for Russia – 94,6%
• - to newborns – 32 (100%), average for Russia – 99%
• - 3-stage – 29 (90,6%)
 One women started receiving chemotherapy in labours, one only received
drugs during pregnancy, and one more never received chemotherapy.
 All 100% newborns received chemotherapy.
 PCR testing gave no positive results for children born in 2016
Министерство здравоохранения
Республики Карелия
2017
In January-May 2017, 12 child deliveries and 3 abortions were recorded
10 mother-child couples received chemoprevention
In 2 cases chemoprevention was not done to women in pregnancy (refusal)
and labours
100% of children received chemoprevention
9 women had undetectable viral load
PCR was done to 11 children (in one case blood could not be taken from a
child with little weight, another attempt will be done at 2-months age),
including children whose mothers had ni chemotherapy. All results were
negative.
Министерство здравоохранения
Республики Карелия
Министерство здравоохранения
и социального развития Республики Карелия
Commission on MTCT prevention
 Tasks of the Commission
 Discusses and settles questions of medical care to HIV+ pregnant women,
parturients, children born to HIV+ mothers.
 Gives recommendations on managing HIV+ pregnant women, managing labours,
follow-up of newborns, monitoring of how recommendations are carried out.
 Analysis of MTCT prevention measures in pregnancy, labours, to newborns in all
child delivery outcomes among HIV+ women
 Consideration of all MTCT cases
Министерство здравоохранения
и социального развития Республики Карелия
Commission on MTCT prevention
 Regulations
 Meetings when needed, but at least once in three months
 Healthcare organisations submit (upon request of the Commission’s secretary)
medical records for HIV+ pregnant women, parturients, children born to HIV+
mothers.
 Specialists from healthcare organisations take part at the meetings of the
Commission upon invitation
 Commission’s decisions are documented in the minutes of the meeting.
 Commission’s recommendations are documented into the medical records.
 Annually, the Commission submits information about the results to the Ministry
of Health of the Republic of Karelia
Министерство здравоохранения
и социального развития Республики Карелия
Thank you for attention

More Related Content

What's hot

Importance of HIV testing and linkage to care
Importance of HIV testing and linkage to careImportance of HIV testing and linkage to care
Importance of HIV testing and linkage to care
European Centre for Disease Prevention and Control
 
The 2016 Autism Self-Assessment in South west
The 2016 Autism Self-Assessment in South westThe 2016 Autism Self-Assessment in South west
The 2016 Autism Self-Assessment in South west
Public Health England
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
European Centre for Disease Prevention and Control
 
The 2016 Autism Self-Assessment in South east
The 2016 Autism Self-Assessment in South eastThe 2016 Autism Self-Assessment in South east
The 2016 Autism Self-Assessment in South east
Public Health England
 
Aia update ri task force meet 20th jan
Aia update ri task force meet 20th janAia update ri task force meet 20th jan
Aia update ri task force meet 20th jan
Maiwand Ahmadzai
 
Experience from Ireland 2014. Stephen Murchan (Ireland)
Experience from Ireland 2014.  Stephen Murchan (Ireland)Experience from Ireland 2014.  Stephen Murchan (Ireland)
Experience from Ireland 2014. Stephen Murchan (Ireland)
European Centre for Disease Prevention and Control (ECDC)
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...
European Centre for Disease Prevention and Control
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
European Centre for Disease Prevention and Control
 
The 2016 Autism Self-Assessment in Yorkshire and Humber
The 2016 Autism Self-Assessment in Yorkshire and HumberThe 2016 Autism Self-Assessment in Yorkshire and Humber
The 2016 Autism Self-Assessment in Yorkshire and Humber
Public Health England
 
WGHA Discovery Series: Cathering Wilfert
WGHA Discovery Series: Cathering WilfertWGHA Discovery Series: Cathering Wilfert
WGHA Discovery Series: Cathering Wilfert
UWGlobalHealth
 

What's hot (10)

Importance of HIV testing and linkage to care
Importance of HIV testing and linkage to careImportance of HIV testing and linkage to care
Importance of HIV testing and linkage to care
 
The 2016 Autism Self-Assessment in South west
The 2016 Autism Self-Assessment in South westThe 2016 Autism Self-Assessment in South west
The 2016 Autism Self-Assessment in South west
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
 
The 2016 Autism Self-Assessment in South east
The 2016 Autism Self-Assessment in South eastThe 2016 Autism Self-Assessment in South east
The 2016 Autism Self-Assessment in South east
 
Aia update ri task force meet 20th jan
Aia update ri task force meet 20th janAia update ri task force meet 20th jan
Aia update ri task force meet 20th jan
 
Experience from Ireland 2014. Stephen Murchan (Ireland)
Experience from Ireland 2014.  Stephen Murchan (Ireland)Experience from Ireland 2014.  Stephen Murchan (Ireland)
Experience from Ireland 2014. Stephen Murchan (Ireland)
 
Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...Scaling-up harm reduction services to prevention HIV among people who inject ...
Scaling-up harm reduction services to prevention HIV among people who inject ...
 
Community-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiativeCommunity-based HIV testing: the Athens Checkpoint initiative
Community-based HIV testing: the Athens Checkpoint initiative
 
The 2016 Autism Self-Assessment in Yorkshire and Humber
The 2016 Autism Self-Assessment in Yorkshire and HumberThe 2016 Autism Self-Assessment in Yorkshire and Humber
The 2016 Autism Self-Assessment in Yorkshire and Humber
 
WGHA Discovery Series: Cathering Wilfert
WGHA Discovery Series: Cathering WilfertWGHA Discovery Series: Cathering Wilfert
WGHA Discovery Series: Cathering Wilfert
 

Similar to HIV incidence in Republic of Karelia. Chemoprevention of mother-to-child transmission of HIV_ eng

Archangelsk region abridged_eng
Archangelsk region abridged_engArchangelsk region abridged_eng
Archangelsk region abridged_eng
THL
 
MMWR elimination of mtct thailand june 2016
MMWR elimination of mtct thailand june 2016MMWR elimination of mtct thailand june 2016
MMWR elimination of mtct thailand june 2016
Chuchai Sornchumni
 
Hiv negative children delivered by hiv positive mothers
Hiv negative children delivered by hiv positive mothers Hiv negative children delivered by hiv positive mothers
Hiv negative children delivered by hiv positive mothers
Sarah Agbonkhese
 
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
THL
 
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
THL
 
1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt
ssuser0c2aba
 
Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...
Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...
Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
 
HIV Updates in Diagnosis and Management.pptx
HIV Updates in Diagnosis and Management.pptxHIV Updates in Diagnosis and Management.pptx
HIV Updates in Diagnosis and Management.pptx
ssuser38ed4c2
 
2018 SUPACA Youth Forum on HIV
2018 SUPACA Youth Forum on HIV2018 SUPACA Youth Forum on HIV
2018 SUPACA Youth Forum on HIV
Helen Madamba
 
Philippine Health Care Delivery System
Philippine Health Care Delivery SystemPhilippine Health Care Delivery System
Philippine Health Care Delivery System
Ryan Michael Oducado
 
Session-16-HIV-and-Replacement-Feeding-revised-2012.ppt
Session-16-HIV-and-Replacement-Feeding-revised-2012.pptSession-16-HIV-and-Replacement-Feeding-revised-2012.ppt
Session-16-HIV-and-Replacement-Feeding-revised-2012.ppt
Medidas Medical Center INC
 
Ending AIDS in children and adolescents: Is it a pipe dream?
Ending AIDS in children and adolescents: Is it a pipe dream?Ending AIDS in children and adolescents: Is it a pipe dream?
Ending AIDS in children and adolescents: Is it a pipe dream?
UNICEF Office of Research - Innocenti
 
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACP
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACPHIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACP
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACP
Dr Munawar Khan
 
National aids control programme
National  aids control programmeNational  aids control programme
National aids control programme
Dr.Jatheesh Mohan
 
Anti-retroviral therapy in HIV-positive pregnant women and children
Anti-retroviral therapy in HIV-positive pregnant women and childrenAnti-retroviral therapy in HIV-positive pregnant women and children
Anti-retroviral therapy in HIV-positive pregnant women and children
Zeena Nackerdien
 
Enabling Policy environments for more effective HIV Responses among Gay and B...
Enabling Policy environments for more effective HIV Responses among Gay and B...Enabling Policy environments for more effective HIV Responses among Gay and B...
Enabling Policy environments for more effective HIV Responses among Gay and B...
MSMGF
 
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentation
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser PresentationPreventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentation
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentation
mothers2mothers
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
ssuserd6cc4b
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
Harsh Rastogi
 
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016
Statistics South Africa
 

Similar to HIV incidence in Republic of Karelia. Chemoprevention of mother-to-child transmission of HIV_ eng (20)

Archangelsk region abridged_eng
Archangelsk region abridged_engArchangelsk region abridged_eng
Archangelsk region abridged_eng
 
MMWR elimination of mtct thailand june 2016
MMWR elimination of mtct thailand june 2016MMWR elimination of mtct thailand june 2016
MMWR elimination of mtct thailand june 2016
 
Hiv negative children delivered by hiv positive mothers
Hiv negative children delivered by hiv positive mothers Hiv negative children delivered by hiv positive mothers
Hiv negative children delivered by hiv positive mothers
 
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
 
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
Assessment of MTCT prevention effectiveness in Kaliningrad Region and tasks f...
 
1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt1.HIV Background and Epidemiology - Copy (2).ppt
1.HIV Background and Epidemiology - Copy (2).ppt
 
Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...
Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...
Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...
 
HIV Updates in Diagnosis and Management.pptx
HIV Updates in Diagnosis and Management.pptxHIV Updates in Diagnosis and Management.pptx
HIV Updates in Diagnosis and Management.pptx
 
2018 SUPACA Youth Forum on HIV
2018 SUPACA Youth Forum on HIV2018 SUPACA Youth Forum on HIV
2018 SUPACA Youth Forum on HIV
 
Philippine Health Care Delivery System
Philippine Health Care Delivery SystemPhilippine Health Care Delivery System
Philippine Health Care Delivery System
 
Session-16-HIV-and-Replacement-Feeding-revised-2012.ppt
Session-16-HIV-and-Replacement-Feeding-revised-2012.pptSession-16-HIV-and-Replacement-Feeding-revised-2012.ppt
Session-16-HIV-and-Replacement-Feeding-revised-2012.ppt
 
Ending AIDS in children and adolescents: Is it a pipe dream?
Ending AIDS in children and adolescents: Is it a pipe dream?Ending AIDS in children and adolescents: Is it a pipe dream?
Ending AIDS in children and adolescents: Is it a pipe dream?
 
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACP
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACPHIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACP
HIV/AIDS and Sindh ,Pakistan by Dr Munawar Khan SACP
 
National aids control programme
National  aids control programmeNational  aids control programme
National aids control programme
 
Anti-retroviral therapy in HIV-positive pregnant women and children
Anti-retroviral therapy in HIV-positive pregnant women and childrenAnti-retroviral therapy in HIV-positive pregnant women and children
Anti-retroviral therapy in HIV-positive pregnant women and children
 
Enabling Policy environments for more effective HIV Responses among Gay and B...
Enabling Policy environments for more effective HIV Responses among Gay and B...Enabling Policy environments for more effective HIV Responses among Gay and B...
Enabling Policy environments for more effective HIV Responses among Gay and B...
 
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentation
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser PresentationPreventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentation
Preventing MTCT in Africa: Using New Paradigms - A Dr Besser Presentation
 
nationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdfnationalaidscontrolprogrammenacp-210419063636.pdf
nationalaidscontrolprogrammenacp-210419063636.pdf
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
 
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016
South Africa Demographic and Health Survey 2016: Key Indicators Report, 2016
 

More from THL

Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021
THL
 
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfNiiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
THL
 
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfYlitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
THL
 
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfNieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
THL
 
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfRaitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
THL
 
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
THL
 
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfLansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
THL
 
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfMarkkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
THL
 
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
THL
 
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoRikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
THL
 
Synthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeSynthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in Europe
THL
 
Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021
THL
 
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
THL
 
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfAktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
THL
 
Kort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerKort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationer
THL
 
Förvaring av vacciner
Förvaring av vaccinerFörvaring av vacciner
Förvaring av vacciner
THL
 
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
THL
 
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluHanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
THL
 
Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022
THL
 
Tietoisku eri rokotteista
Tietoisku eri rokotteistaTietoisku eri rokotteista
Tietoisku eri rokotteista
THL
 

More from THL (20)

Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021Somaattinen erikoissairaanhoito 2021
Somaattinen erikoissairaanhoito 2021
 
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdfNiiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
Niiranen_Jalkautuvan_nuorisotyon_vaikutusten_ennakkoarviointi_27092022.pdf
 
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdfYlitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
Ylitalo_EPT_vaikutusten_ennakkoarviointi_tulevaisuudessa_27092022.pdf
 
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdfNieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
Nieminen_Niemi_Kuntaliitto_Mita_on_paatosten_EVA_Tyokalu_tutuksi_27092022.pdf
 
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdfRaitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
Raitasalo_Nuorten_paihteidenkayton_yleiskuva_10102022.pdf
 
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
Hietanen_Peltola_Jahnukainen_Miten_opiskeluhuoltopalvelut_tukevat_hyvinvointi...
 
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdfLansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
Lansikallio_Paihdekasvatus_EPT_oppilaitoksissa_10102022.pdf
 
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdfMarkkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
Markkula_Vaikuttava ehkaiseva paihdetyo_10102022.pdf
 
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022Erikoissairaanhoidon hoitoonpääsy 31.08.2022
Erikoissairaanhoidon hoitoonpääsy 31.08.2022
 
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilastoRikos- ja riita-asioiden sovittelu 2021 -tilasto
Rikos- ja riita-asioiden sovittelu 2021 -tilasto
 
Synthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in EuropeSynthetic Opioid Preparedness in Europe
Synthetic Opioid Preparedness in Europe
 
Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021Sosiaalihuollon laitos- ja asumispalvelut 2021
Sosiaalihuollon laitos- ja asumispalvelut 2021
 
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022Hoitoonpääsy perusterveydenhuollossa keväällä 2022
Hoitoonpääsy perusterveydenhuollossa keväällä 2022
 
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdfAktuellt om coronavaccinationer - vaccinering under sommaren.pdf
Aktuellt om coronavaccinationer - vaccinering under sommaren.pdf
 
Kort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationerKort information och aktuella frågor om vaccinationer
Kort information och aktuella frågor om vaccinationer
 
Förvaring av vacciner
Förvaring av vaccinerFörvaring av vacciner
Förvaring av vacciner
 
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
Johannes Kohal: Henkilöstömitoituksen seurantaan tarvittavat tiedot ja tiedon...
 
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikatauluHanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
Hanna Alastalo: Henkilöstömitoituksen seurannan kehitys ja aikataulu
 
Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022Ajankohtaista koronarokotuksista 2.6.2022
Ajankohtaista koronarokotuksista 2.6.2022
 
Tietoisku eri rokotteista
Tietoisku eri rokotteistaTietoisku eri rokotteista
Tietoisku eri rokotteista
 

Recently uploaded

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 

Recently uploaded (20)

Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 

HIV incidence in Republic of Karelia. Chemoprevention of mother-to-child transmission of HIV_ eng

  • 1. HIV incidence in Republic of Karelia. Chemoprevention of mother-to-child transmission of HIV Министерство здравоохранения Республики Карелия Kaliningrad Elena Kuzmicheva
  • 2. HIV incidence and prevalence in Republic of Karelia In 2016, 175 HIV cases were diagnosed, of whom 161 among residents of Karelia. HIV incidence amounted to 25,5 per 100,000 population, which is by 11,5% lower than the 2015 incidence rate From January to May 2017, 78 HIV cases were diagnosed, of whom 72 were residents of Karelia. The incidence was 11,4 per 100,000 population, which is by 22,6% higher than in the similar period of 2016 (9,3 per 100,000) As of 1.6.2017, totally 1,989 HIV cases were diagnosed in Karelia, of whom 1,662 were Karelia’s residents. The prevalence is 263,9 per 100,000 population. Министерство здравоохранения Республики Карелия
  • 3. HIV incidence and prevalence Министерство здравоохранения Республики Карелия incidence
  • 4. HIV incidence and prevalence by municipality • In some municipalities the HIV rates are higher than the Russian average rates (594,3 per 100,000 population as of 1.1.2017) 234,6 445,9 662,5 105,7 212,4 63,5 205,5 453,4 1094,9 139,9 123,4 313,2 263,0 215,3 103,8 158,7 168,8 204,9 263,9 594,3 0,0 200,0 400,0 600,0 800,0 1000,0 Районы республики Республика Карелия Российская Федерация Municipalities Karelia Russia Министерство здравоохранения Республики Карелия
  • 5. Distribution of PLWHs by gender • Women make up 37,3% in the total HIV+ population 62,7% 37,3% 53,7 57,8 67,1 51,7 62,9 69,9 61,8 75,4 60,0 66,5 55,0 55,2 58,5 59,4 61,5 46,3 42,2 32,9 48,3 37,1 30,1 38,2 24,6 40,0 33,5 45,0 44,8 41,5 40,6 38,5 0 % 25 % 50 % 75 % 100 % 2003 г. 2004 г. 2005 г. 2006 г. 2007 г. 2008 г. 2009 г. 2010 г. 2011 г. 2012 г. 2013 г. 2014 г. 2015 г. 2016 г. 2017 г. женщины мужчины Females Males Министерство здравоохранения Республики Карелия
  • 6. Age structure of the HIV+ population • Among all PLWHs, the share of the young population aged 20-29 years is 45,5%, and aged 30-34 years – 34,0% 0-14 лет; 0,6% 15-19 лет; 4,9% 20-29 лет; 45,5% 30-39 лет; 34,0% 40-49 лет; 10,6% 50 и старше; 4,3% Министерство здравоохранения Республики Карелия
  • 7. Changes in the age structure of the HIV+ population • More HIV+ people in senior age groups • In 2011, aged 20-29 made 44,2%, 30-39 years – 39,5%, 40-49 years – 10,9%, Over 50 years – 1,8%. • In 2016, 20-29 years - 19,4%, 30-39 years – 45,7%, 40-49 years – 21,7%, Over 50 years – 9,7%. 0,6 1,2 0,5 0,5 0,62,7 3,0 3,0 1,9 3,3 2,0 2,9 37,7 44,2 44,3 35,0 35,0 36,5 19,4 23,1 41,2 39,5 37,1 41,9 40,4 40,5 45,7 35,9 11,4 10,9 9,6 16,2 14,8 16,5 21,7 28,2 7,0 1,8 4,8 5,0 6,0 4,0 9,7 12,8 0 % 10 % 20 % 30 % 40 % 50 % 60 % 70 % 80 % 90 % 100 % 2010г. 2011г. 2012г. 2013г. 2014г. 2015г. 2016г. 2017г. 50 и старше 40-49 лет 30-39 лет 20-29 лет 15-19 лет 0-14 лет Министерство здравоохранения Республики Карелия
  • 8. Age structure of HIV+ women • Women prevail over men in age groups 15-19 years, 20-29 years and over 50 years. The leading age groups, alike with men, are 20-29 years and 30-39 years 0-14 yo; 0,3% 15-19 yo; 6,9% 20-29 yo; 46,1% 30-39 yo; 29,6% 40-49 yo; 10,8% 50 and older; 6,3% Министерство здравоохранения Республики Карелия
  • 9. Key transmission routes 43 % 55 % 1 %0 % 1 % Заражение при употреблении в/в наркотиков Заражение при гетеросексуальных контактах Заражение при гомосексуальных контактах Заражение при парентеральных вмешательствах в ЛПУ Заражение от матери во время беременности и родов Министерство здравоохранения Республики Карелия IDU Heterosexual contacts Homosexual contacts Blood products in healthcare sector Mother-to-child
  • 10. Key transmission routes 32,7 51,3 54,3 40,6 41,4 45,1 40,8 34,1 28,6 33,3 30,3 27,8 65,5 47,4 44,7 52,2 58,6 54,0 56,9 65,1 69,4 64,2 68,0 70,4 0 % 10 % 20 % 30 % 40 % 50 % 60 % 70 % 80 % 90 % 100 % 2006 г. 2007 г. 2008 г. 2009 г. 2010 г. 2011 г. 2012 г. 2013 г. 2014 г. 2015 г. 2016 г. 2017 г. Заражение при употреблении в/в наркотиков Заражение при гомосексуальных контактах Заражение при гетеросексуальных контактах Заражение от матери во время беременности и родов Заражение при парентеральных вмешательствах в ЛПУ IDU Heterosexual contacts Blood products Homosexual contacts MTCT Министерство здравоохранения Республики Карелия
  • 11. Follow-up care for pregnant women and children born to HIV+ mothers As of 01.06.2017: Abortion – 145 Deliveries – 284, of which in 2016 – 32, in 2017 - 12. HIV diagnosed with 11 children, of whom born in Karelia – 10 (of whom in 2014 – 1, in 2015 – 1, in 2016 – 1). Died of HIV – 2 children, moved from Karelia – 2. Under follow-up – 9 children (7 born in Karelia and 2 arrived from other regions). All receive ARVT Министерство здравоохранения Республики Карелия
  • 12. Child deliveries among HIV+ women in Republic of Karelia 1 8 5 10 8 11 7 16 18 16 26 20 28 35 31 32 12 0 10 20 30 1999 г.2000 г.2001 г.2002 г.2003 г.2004 г.2005 г.2006 г.2007 г.2008 г.2009 г.2010 г.2011 г.2012 г. 2013г. 2014г. 2015г. 2016г. 2017г. Absolutenumber Министерство здравоохранения Республики Карелия
  • 13. Coverage with chemotherapy 80,8 95,0 89,3 97,1 96,9 93,7 83,3 80,8 85,0 82,2 88,6 93,7 93,7 83,3 96,1 100,0 96,4 100,0 100,0 100,0 100 80,8 85,0 82,2 88,6 93,7 90,6 83,3 0,0 20,0 40,0 60,0 80,0 100,0 2011 2012 2013 2014 2015 2016 2017 % беременных, получивших ВААРТ или ХП во время беременности % беременных, получивших ХП во время родов % новорожденных, получивших ХП % пар мать-дитя, получвших трехэтапную ХП Министерство здравоохранения Республики Карелия % of pregnant women who received ARVT or chemotherapy during pregnancy % of pregnant women who received chemotherapy during pregnancy % of newborns who received chemotherapy % of mother-child couples who received 3-stage chemotherapy
  • 14. Summary of 2016 In 2016, out of 32 pregnant women, 30 were in follow-up in women’s clinics and AIDS Centre (93,7%), average for Russia – 92,0%.  Chemotherapy: • - in pregnancy– 30 (93,7%), average for Russia – 89%,  29 women had undetectable viral load (91,6%, average for Russia – 79%) • - during labours – 30 (93,7%), average for Russia – 94,6% • - to newborns – 32 (100%), average for Russia – 99% • - 3-stage – 29 (90,6%)  One women started receiving chemotherapy in labours, one only received drugs during pregnancy, and one more never received chemotherapy.  All 100% newborns received chemotherapy.  PCR testing gave no positive results for children born in 2016 Министерство здравоохранения Республики Карелия
  • 15. 2017 In January-May 2017, 12 child deliveries and 3 abortions were recorded 10 mother-child couples received chemoprevention In 2 cases chemoprevention was not done to women in pregnancy (refusal) and labours 100% of children received chemoprevention 9 women had undetectable viral load PCR was done to 11 children (in one case blood could not be taken from a child with little weight, another attempt will be done at 2-months age), including children whose mothers had ni chemotherapy. All results were negative. Министерство здравоохранения Республики Карелия
  • 16. Министерство здравоохранения и социального развития Республики Карелия Commission on MTCT prevention  Tasks of the Commission  Discusses and settles questions of medical care to HIV+ pregnant women, parturients, children born to HIV+ mothers.  Gives recommendations on managing HIV+ pregnant women, managing labours, follow-up of newborns, monitoring of how recommendations are carried out.  Analysis of MTCT prevention measures in pregnancy, labours, to newborns in all child delivery outcomes among HIV+ women  Consideration of all MTCT cases
  • 17. Министерство здравоохранения и социального развития Республики Карелия Commission on MTCT prevention  Regulations  Meetings when needed, but at least once in three months  Healthcare organisations submit (upon request of the Commission’s secretary) medical records for HIV+ pregnant women, parturients, children born to HIV+ mothers.  Specialists from healthcare organisations take part at the meetings of the Commission upon invitation  Commission’s decisions are documented in the minutes of the meeting.  Commission’s recommendations are documented into the medical records.  Annually, the Commission submits information about the results to the Ministry of Health of the Republic of Karelia
  • 18. Министерство здравоохранения и социального развития Республики Карелия Thank you for attention